P-126 - POPULATION PHARMACOKINETICS (POPPK) MODELING AND EXPOSURE-RESPONSE (E-R) RELATIONSHIP ANALYSES OF CEMIPLIMAB (CEMI) IN PATIENTS (PTS) WITH RECURRENT OR METASTATIC CERVICAL CANCER (R/M CC).
J. Nguyen1, D. Epling2, N. Dolphin2, A. Paccaly1, J. Davis1, N. Al-Huniti1; 1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA, 2Ann Arbor Pharmacometrics Group, Ann Arbor, MI, USA.
.jpg "Jenny-Hoa Nguyen, MS photo")
.png)